Career Opportunities in the Foresite Capital Network

How you will Achieve More with Intellia:

The Medical Affairs Lead (MAL) NTLA-2002 is a MD/PharmD with solid history of clinical and pharmaceutical industry experience, ideally in the fields of immunological disorders. The candidate will also have strong experience in product launches, including proven ability to translate and appropriately align commercial and medical goals and objectives. The MAL will be a key member of the Medical Affairs Leadership Team and report to the Head of Medical Affairs (HMA). This will be a highly visible role responsible for developing and leading medical affairs plans in close collaboration with cross-functional teams, contributing to clinical strategy, collaborating to develop impactful medical education, evidence generation and healthcare system and key stakeholders engagement plans. In addition, the Medical Affairs Lead will be accountable for operational oversight of execution of the plans.

You will be responsible for the following:

• Co-lead the Integrated Brand Team for NTLA-2002, our lead investigational therapy for the treatment of Hereditary Angioedema, together and in close partnership with the Program Brand Lead.

• Responsible for the development of short-term and long-term strategy, as well as execution of the program medical affairs plan as a key component of the integrated brand plan and in full support of the key strategic imperatives.

• Accountable for the alignment of all global medical affairs activities in close partnership with other members of the Integrated Brand Team and Program Leadership Team.

• Accountable for the medical accuracy and fair balance of medical information in educational and other medical communication and learning materials for both internal and external use.

• Collaborate with other line functions (Clinical Development, HEOR, etc.) to ensure that the medical evidence generation plan is aligned with the NTLA-2002 program objectives.

• Engage with and prioritize key stakeholders identified as strategic partners, including advocacy groups, medical societies, payers, and provider groups as well as medical experts in ATTR amyloid cardiomyopathy and polyneuropathy.

• Work closely with Patient Advocacy, Medical Engagement and Regional Scientific Leads to develop and execute medical engagement strategy

• Play an integral role in the planning and participation of national and regional medical advisory boards.

• Provide medical input into the safety profile of the product in collaboration with Clinical Development and Patient Safety (PS) colleagues.

• Collaborate with all Medical Affairs functions and work closely with Access & HEOR to support key educational, engagement and evidence generation initiatives.

• Provide clinical support to the design and execution of HEOR studies, outcomes surveys, etc. in close collaboration with HEOR/Access colleagues.

• Work closely with Clinical Development team to ensure optimal collaboration and inclusion of external clinicians/KOLs and other relevant healthcare system stakeholders in clinical trial planning, enrollment, and interpretation

• Interact with investigators, KOLs, research institutions, and centers of excellence to oversee and support Medical Affairs objectives.

• Collaborate with the Scientific Communications team supporting the review and approval of publications and resources ensuring medical accuracy and alignment of all communication materials.

Lead Intellia Medical Affairs initiatives at key congress meetings and conferences. This includes leading content development and presentation for internal and external medical education programs as needed.

About You:

You are a key Medical Affairs leader who would embrace the challenge to create an innovative US and global Medical Affairs approach to support Intellia’s CRISPR/cas9 programs.

Qualifications

• MD/Pharm D with significant (>10y) experience in Medical Affairs and Clinical Development in the biotechnology/pharmaceutical industry.

• Experience in Medical Affairs leadership for products addressing rare diseases, with strong therapeutic area knowledge relevant to mechanism of action of NTLA-2002.

• Robust clinical research experience within the pharmaceutical/biotech industry.

• Previous experience successfully leading a medical affairs/clinical development team with responsibility for late-stage clinical studies across multiple regions.

• Solid communication, strategic, interpersonal, and negotiating skills, with ability to proactively predict challenges and solve problems.

• Ability to drive decision-making within a multi-disciplinary, multi-regional, matrix teams

• Diplomacy and positive influencing abilities.

• Knowledge of both regional and global Regulatory requirements.

• Track record of successful and emerging research in therapeutic areas relevant to Intellia’s development programs and pipeline.

• Demonstrated ability to lead and motivate a team; experience leading cross-functional teams and vendors/consultants.

• Demonstrated ability to present complex issues to upper-level management and contribute to executive level presentations and discussions.

• Excellent interpersonal skills with an ability to respond to multiple external and internal queries, managing and handling conflict constructively.

• Success working in a fast paced, matrixed, growing organization, partnering with multiple internal & external stakeholders.

Meet your future team:

The Medical Affairs Team at Intellia is here because we believe genome editing has incredible potential to treat and cure life-threatening and fatal diseases, and we believe that Intellia has the right people, strategy, and culture to do it well. It is made up of outstanding professionals in functions related to clinical research, including but not limited to biometrics, clinical operations, clinical pharmacology, medical science, medical writing, project leadership, project management, and regulatory affairs. The team is led by our Head of Medical Affairs, a physician scientist with over 25 years of experience in academia and industry drug development. Other senior team members have 10 or more years of similar experience, including many with prior direct experience in nucleic acid therapeutics and cell therapy.

Covid-19 Vaccination Policy: All Intellia employees, regardless of work location, must be fully vaccinated for COVID-19. This requirement includes a booster dose once eligible. Requests for exemption for medical or sincerely held religious beliefs will be considered.

EEOC Statement: Intellia believes in a diverse environment, and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Intellia will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.